Nuveen Asset Management, LLC Elevation Oncology, Inc. Transaction History
Nuveen Asset Management, LLC
- $340 Billion
- Q4 2024
A detailed history of Nuveen Asset Management, LLC transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 174,137 shares of ELEV stock, worth $83,585. This represents 0.0% of its overall portfolio holdings.
Number of Shares
174,137
Previous 174,137
-0.0%
Holding current value
$83,585
Previous $104,000
3.85%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ELEV
# of Institutions
71Shares Held
39.1MCall Options Held
100Put Options Held
3.3K-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.99MShares$2.88 Million0.21% of portfolio
-
Tang Capital Management LLC San Diego, CA4.76MShares$2.28 Million0.21% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.53MShares$1.69 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA2.97MShares$1.42 Million0.06% of portfolio
-
Aisling Capital Management LP New York, NY2.83MShares$1.36 Million0.6% of portfolio
About Elevation Oncology, Inc.
- Ticker ELEV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,300,900
- Market Cap $11.2M
- Description
- Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...